10.09.2010
BC-3781 Shows Therapeutic Potential
02.06.2010
Phase II of pleuromutilin antibiotic BC-3781
31.05.2010
Nabriva nominated as a finalist for the 2010 Red Herring 100 Europe Award
12.04.2010
Nabriva reports successful Phase I clinical trial for BC-3781
© Nabriva Therapeutics Forschungs GmbH